Leprosy Research Initiative   Report issue

Foundation
Founded: Amsterdam Netherlands (2013)

Organization Overview

First Clinical Trial
2019
NCT03775460
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Leprosy Research Initiative

Active Ingredients

Drugs in Other Trials (2)

methotrexate (1 trial)

prednisolone (hydeltra) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2